Early Lethal Noncompaction Cardiomyopathy in Siblings With Compound Heterozygous RYR2 Variant

Can J Cardiol. 2021 Nov;37(11):1864-1866. doi: 10.1016/j.cjca.2021.04.023. Epub 2021 May 10.

Abstract

Two siblings presented with early lethal noncompaction cardiomyopathy (NCCM). Both carry compound heterozygous variants in the ryanodine receptor gene (RYR2). Evolving animal and human data have begun to implicate a role for RYR2 dysfunction in the development of NCCM. The identified RYR2 variants are therefore likely causative for this early lethal NCCM phenotype. Further research is needed to understand the role of RYR2 in the heart compaction process.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • DNA / genetics*
  • DNA Mutational Analysis
  • Echocardiography
  • Electrocardiography
  • Fatal Outcome
  • Female
  • Humans
  • Infant, Newborn
  • Isolated Noncompaction of the Ventricular Myocardium / diagnosis
  • Isolated Noncompaction of the Ventricular Myocardium / genetics*
  • Isolated Noncompaction of the Ventricular Myocardium / metabolism
  • Male
  • Mutation*
  • Pedigree
  • Phenotype
  • Ryanodine Receptor Calcium Release Channel / genetics*
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Siblings*

Substances

  • RyR2 protein, human
  • Ryanodine Receptor Calcium Release Channel
  • DNA